No Data
No Data
No Data
No Data
No Data
Express News | Rigel Pharmaceuticals: on April 11, Entered Amendment to Credit & Security Deal of Sept 27, 2019 to Extend Maturity for Term Loans to Sept 1, 2027
Moomoo 24/7Apr 12 08:09 ET
Rigel Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel's Inducement Plan, approved by the...
PR NewswireApr 10 16:30 ET
Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients With Mutant IDH1 AML in Leukemia & Lymphoma
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a peer-reviewed publication in Leukemia & Lymphoma on data from an analysis of the Phase 2 ...
PR NewswireApr 4 08:05 ET
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Dow JonesMar 12 08:05 ET
Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
Yahoo FinanceMar 7 13:50 ET
Rigel Pharmaceuticals Is Maintained at Buy by Citigroup
Rigel Pharmaceuticals Is Maintained at Buy by Citigroup
Dow JonesMar 7 09:41 ET
Jenna Ragan : I'm holding and loading
TrytosaveabitOP Jenna Ragan: Im liking it a lot still! GL little lady!
Kevin Lehmann : going to jump
Jenna RaganOP Kevin Lehmann: it will be another $Candel Therapeutics (CADL.US)$
Kevin Lehmann : bearish spinning top next going up late today
No Data
No Data